Divergent opioid-mediated suppression of inhibition between hippocampus and neocortex across species and development

不同物种和发育阶段海马和新皮层中阿片类药物介导的抑制作用存在差异

阅读:2
作者:Adam P Caccavano ,Anna Vlachos ,Nadiya McLean ,Sarah Kimmel ,June Hoan Kim ,Geoffrey Vargish ,Vivek Mahadevan ,Lauren Hewitt ,Anthony M Rossi ,Ilona Spineux ,Sherry Jingjing Wu ,Elisabetta Furlanis ,Min Dai ,Brenda Leyva Garcia ,Yating Wang ,Ramesh Chittajallu ,Edra London ,Xiaoqing Yuan ,Steven Hunt ,Daniel Abebe ,Mark A G Eldridge ,Alex C Cummins ,Brendan E Hines ,Anya Plotnikova ,Arya Mohanty ,Bruno B Averbeck ,Kareem A Zaghloul ,Jordane Dimidschstein ,Gord Fishell ,Kenneth A Pelkey ,Chris J McBain
Within adult rodent hippocampus (HPC), opioids suppress inhibitory parvalbumin-expressing interneurons (PV-INs), disinhibiting local microcircuits. However, it is unknown whether this disinhibitory motif is conserved across cortical regions, species, or development. We observed that PV-IN-mediated inhibition is robustly suppressed by opioids in HPC proper but not primary neocortex in mice and non-human primates, with spontaneous inhibitory tone in resected human tissue also following a consistent dichotomy. This hippocampal disinhibitory motif is established in early development when PV-INs and opioids regulate early population activity. Morphine pretreatment partially occludes this acute opioid-mediated suppression, with implications for the effects of opioids on hippocampal network activity important for learning and memory. Our findings demonstrate that PV-INs exhibit divergent opioid sensitivity across brain regions, which is remarkably conserved over evolution, and highlight the underappreciated role of opioids acting through immature PV-INs in shaping hippocampal development.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。